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Abstract
Background: Apps have been enthusiastically adopted by the general public. They are increasingly recognized by
policy-makers as a potential medium for supporting self-management of long-term conditions. We assessed the
degree to which current smartphone and tablet apps for people with asthma offer content and tools of
appropriate quality to support asthma self-management.
Methods: We adapted systematic review methodology to the assessment of apps. We identified English-language
asthma apps for all ages through a systematic search of official app stores. We systematically assessed app content
using criteria derived from international guidelines and systematic review of strategies for asthma self-
management. We covered three domains: comprehensiveness of asthma information, consistency of advice with
evidence and compliance with health information best practice principles.
Results: We identified 103 apps for asthma in English, of which 56 were sources of information about the
condition and 47 provided tools for the management of asthma. No apps offered both types of functionality. Only
three information apps approached our definition of comprehensiveness of information about asthma. No apps
provided advice on lay management of acute asthma that included details of appropriate reliever medication use.
In 32 of 72 instances, apps made unequivocal recommendations about strategies for asthma control or prophylaxis
that were unsupported by current evidence. Although 90% of apps stated a clear purpose, compliance with other
best practice principles for health information was variable. Contact details were located for 55%, funding source
for 18% and confidentiality policy for 17%.
Conclusions: No apps for people with asthma combined reliable, comprehensive information about the condition
with supportive tools for self-management. Healthcare professionals considering recommending apps to patients
as part of asthma self-management should exercise caution, recognizing that some apps like calculators may be
unsafe; that no current app will meet the need of every patient; and that ways of working must be adapted if
apps are to be introduced, supported and sustained in routine care. Policy-makers need to consider the potential
role for assurance mechanisms in relation to apps. There remains much to be done if apps are to find broad use in
clinical practice; clinicians cannot recommend tools that are inaccurate, unsafe or lack an evidence base.
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Background
Apps, software specifically designed for and available on
smartphones and tablets, have been enthusiastically
adopted by users of smartphones and tablets and pro-
posed as a delivery mechanism for self-management
health interventions [1,2]. Forty-two percent of US
adults have a phone with one or more apps and almost
a third of these report having an app to help track or
manage their health [3]. Policy-makers, concerned about
growing demand associated with long-term conditions,
think apps for patients might offer a scalable and conve-
nient way to support the range of needs associated with
self-management. Indeed, the UK Department of Health
has suggested that apps be ‘prescribed’ as part of care
for long-term conditions [4]. Proposals such as these * Correspondence: josip.car@imperial.ac.uk
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suitable for this kind of use.
We address this by focussing on apps for asthma as a
representative long-term condition. Asthma is common,
globally-relevant, managed substantially in primary care
and amenable to self-management. Moreover, while both
the content of asthma self-management education has
been well described in UK [5], US [6] and international
[7] evidence-based guidelines, and its positive impact on
outcomes demonstrated [8], the best way to communi-
cate information and support its use through tools is less
clear. Established methods such as face-to-face education
and paper-based tools are inconsistently applied. For
example, in the UK, only 20% of patients have ever
received a written action plan [9]. Meanwhile, people
with asthma are looking for alternatives; 65% report hav-
ing used the internet to locate information about asthma
without necessarily involving a health professional.
T a k e nt o g e t h e r ,t h e s ec r e a t eas p e c i f i co p p o r t u n i t yf o r
new methods to support self-management education.
This opportunity can only be realized if apps offer con-
tent and tools of appropriate quality. We adapted princi-
ples from systematic literature reviews to assess the
content quality of smartphone and tablet apps for asthma
against objective criteria derived from evidence-based
guidelines [5]. We discuss our findings about asthma
apps in relation to the wider policy context of prescribing
apps to support the care and management of long-term
conditions.
Methods
Selection of apps
W ea i m e dt oi d e n t i f ya l la p p sf o ra s t h m aa c c e s s i b l et o
English-speaking patients. We searched the official app
stores for Android, Apple, Blackberry and Windows
Phone using the following terms: asthma, lung function,
peak flow and inhaler. Apps were downloaded to test
devices for screening by two authors (KH and MC) work-
ing independently using predefined inclusion and exclu-
sion criteria (Figure 1). Test devices were unmodified
consumer-grade smartphones running up-to-date ver-
sions of their mobile operating system. The same version
of each app was used throughout testing.
Planned assessment criteria
Basic details were extracted into a standard form (Addi-
tional file 1). Assessment was performed by two authors
(KH and MC) assessing each app in a random order.
For apps presenting health information about asthma,
we assessed two domains: the comprehensiveness of infor-
mation about asthma and consistency of information with
evidence-based guidelines on asthma. To assess compre-
hensiveness, we assessed coverage of eight topics recom-
mended as the basis of self-management education and
that are consistent across UK, US and international guide-
lines [5-7] (Table 1). For each topic, we assessed coverage
as either ‘complete’, ‘partial’ or ‘absent’.T oe v a l u a t ec o n -
sistency with evidence-based guidelines, we extracted a set
of specific statements relating to secondary prevention and
lifestyle advice from the same guidelines (Table 2). For
each statement, we also captured the direction of the
guideline recommendation indicating whether a particular
strategy was ‘beneficial’, ‘not beneficial’ or whether there
was insufficient or unclear evidence to be able to make a
specific recommendation. To ensure fair assessment of
apps sourced from multiple countries of origin, we
retained only those statements considered by all three
international guidelines used in the review. App content
was reviewed and information corresponding to particular
statements was assessed to see if any recommendation was
consistent with that of the guidelines. Advice about actions
for lay people to take during an asthma attack was com-
pared separately against guidance on initial medical man-
agement for those aged two and older [5].
We used the US National Center for Complementary
and Alternative Medicine definition of Complementary
and Alternative Medicine (CAM) [10] to define a group of
apps that were not assessed for either comprehensiveness
or consistency with evidence since these concepts are not
consistently recognized in CAM practice. However, we
retained these apps within the overall descriptive summary
of app types and, specifically, for assessment of emergency
management advice because of the particular risks asso-
ciated with acute asthma.
In addition to those with information content, we antici-
pated that we would find apps offering diary features and
planned to assess compliance with the recommendations
of a recent systematic review concerning the components
of self-management plans [11]. We also assessed apps
using a set of content-independent quality criteria that we
derived from an existing set of criteria for website-based
health information developed by the Health on the Net
foundation [12] (Table 3). These define a set of eight best-
practice principles relating to attribution, traceability and
transparency of information. For apps that lacked attribu-
tion, we used general purpose internet search engines
(Google, Google Incorporated, Mountain View, CA, USA
and Bing, Microsoft Corporation, Redmond, WA, USA) to
attempt to locate original authors for written content.
Each reviewer recorded their responses in a structured
form. These were compared and any discrepancies were
resolved by discussion. Throughout the assessment pro-
cess, we kept a record of any problems using the software
that were encountered using a general schema to classify
errors (Table 4).
Post-hoc assessments
An additional analysis was performed to assess the
properties of calculator and questionnaire-based apps
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case, we looked for evidence of external validation [13].
We also tested the calculators and any questionnaire
scoring to confirm that these were numerically correct.
Statistics
Descriptive statistics were used to summarize the results
of the content assessment.
Results
Searches performed in August 2011 identified 207 apps
from the app stores for Android, Apple, Blackberry and
Windows Phone, of which 204 were available for screen-
ing (Figure 2). We excluded 101 that either contained no
health or asthma-related content (n = 57), targeted clini-
cians (n = 35), were not in English (n = 7), or could not
be started (n = 2). Excluded apps are summarized in
Additional file 2. Subsequent discussion is restricted to
the 103 apps that met inclusion criteria. Most (n = 94)
were designed for smartphones. Although all iPhone
apps can run on the iPad tablet, we found eight that
included specific customizations to take advantage of the
large screen size and one that was a tablet-only app.
Summary of characteristics of included apps
Fifty-six apps were sources of written (n = 43) and multi-
media (n = 13) information about asthma and its manage-
ment [14-69]. The remaining 47 were tools supporting
aspects of asthma self-management and included diaries
(n = 29), assessment instruments (n = 17) and location-
based alerts (n = 6) [70-115]. Although we neither
expected nor required that assignment into these two
main categories be mutually exclusive, we found no Eng-
lish-language apps that combined both information and
management tools. (A typology is provided in Additional
file 3.) Sixty-one percent (n = 34) of information apps and
96% (n = 45) of management tools focussed on conven-
tional medical management of asthma. Nineteen apps
 
Inclusion criteria
Smartphone or tablet app
Content or tools addressing one or more aspects of asthma diagnosis,
management or support as either
o the sole function; or
o in a way that means asthma-related elements can be isolated from the rest
of the content
Presenting content in any format
English language
Targeted at patients of any age
Free and paid apps
Exclusion criteria
Not available through an approved device marketplace
Explicitly disclaimed use for a health-related purpose
Could not be downloaded because of country restrictions that prevented access in
the United Kingdom
Could not be used because of technicalproblems,after two attempts
Figure 1 Inclusion and exclusion criteria for smartphone apps.
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addressing both approaches. Seven apps targeted either
younger children [38,89] or their parents [16,27,106-108].
None targeted adolescents or elderly patients.
After including any in-app purchases required to access
asthma-specific content, the majority of apps (n = 76/103)
were not free with a median cost of £1.49 (mean £1.85,
range £0.61 to £8.99). Apps offering management tools
were more likely to be free (n = 19/47) compared to those
presenting health information (n = 8/56).
Apps presenting health information
Apps presenting health information are summarized in
Additional file 4.
Comprehensiveness of asthma information
Excluding apps exclusively addressing CAM, 38 apps were
evaluated for comprehensiveness of asthma information
[14-22,24-41,43,48,49,54-56,58,59,63,64,67]. The basic nat-
ure of asthma, including the role of inflammation, symp-
toms and prognosis was the most commonly addressed (at
least partially), by two-thirds of apps (n = 26, breakdown in
Additional file 5). Allergen and trigger avoidance were dis-
cussed by 18 but only covered in depth by 2 [25,63]. Less
than two-fifths addressed recognition of exacerbations
(n = 14), self-monitoring (n = 10) and inhaler techniques
(n = 10). Customized aspects of asthma management,
including the role of an action plan and the prioritization
of treatment goals according to patient wishes, were
addressed least frequently by seven and three apps, respec-
tively. Three apps wholly addressed six of the eight
domains and provided partial coverage of the remaining
two [19,59,63].
Lay management of acute asthma
Of the 14 medical apps containing conventional informa-
tion about recognition and management of acute asthma
[20,25,28,29,33-37,49,58,59,63,64], 7 provided specific
guidance on lay management of an asthma attack.
Although none addressed all aspects of the step-wise
approach recommended by guidelines, six gave advice
that was broadly consistent [33-36,49,63] but lacked spe-
cific instructions on the dose and frequency of reliever
inhaler use (addressed by n = 2/6) or the appropriate
medical service to contact (addressed by n = 2/6). One
a p pp r o v i d e dg u i d a n c et h a ts u b s t a n t i a l l yd i f f e r e df r o m
recommendations [29].
Eight apps suggested CAM procedures for acute
asthma management [35,36,48,51,52,60,62,65]. None
recommended using a beta-agonist reliever inhaler or
Table 1 Items that should be addressed by comprehensive asthma self-management education materials
Topic Criteria
Basic facts about the nature of the condition States that asthma is a lung disease characterized by inflammation and narrowing of the airways
States that the four main symptoms of asthma are cough, wheeze, shortness of breath and chest
tightness
States that asthma cannot be cured (although childhood symptoms may remit) but can be
effectively controlled
States that the cause of asthma is not known
The nature of treatment: relievers and
preventers
States that there are two classes of medication: relievers and preventers
Explains possible side effects of medication (tachycardia/tremor in Β2 agonists; thrush/cataracts/
dysphonia for inhaled steroids; possible additional effects for high dose steroids)
States that early treatment can prevent symptoms from worsening
Allergen and trigger avoidance States that recognizing and avoiding personal triggers is an important part of asthma control
Provides guidance consistent with the primary and Secondary prevention components of the BTS/
SIGN guidelines in relation to specific triggers
How to use treatment States that preventer medication must be used regularly to be effective
States the importance of good inhaler technique and appropriate use of a spacer device
States the importance of ensuring inhalers are in date and are not empty
Self-monitoring and assessment skills States that learning to recognize signs of change in asthma symptoms is an important personal skill
States that all patients with asthma should have a peak flow meter
Explains the purpose of a peak flow meter and how to use it
States the importance of regular physician review
The role of a written, personalized action
plan
States that patients with asthma should have an up to date written action plan. Explains the purpose
of an action plan (to step up and step down treatment, and to seek appropriate help in response to
changing symptoms and/or peak flow)
Recognizing and responding appropriately to
acute exacerbations
Describes signs/symptoms of worsening asthma (increasing wheeze; cough; night time disturbance
breathlessness limiting activity; reliever inhalers not working)
States the importance of changing treatment and/or seeking help promptly
Lay management of acute asthma
Personalizing the definition of good asthma
control
States that it is reasonable for most people to achieve minimal symptoms and limitation of activities
Asks patients to reflect on what they would consider as good asthma control
Advocates discussion with personal health provider to set treatment goals in partnership
Topics were based on UK BTS/SIGN, US EPR-3 and GINA guidelines.
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based recommendations.
Statement Evidence-
base
Rationale for categorization
Secondary prevention-removal of pets
from the home
Uncertain “Complete avoidance of pet allergens is impossible [...] Although removal of such animals
from the home is encouraged, even after permanent removal of the animal it can be many
months before allergen levels decrease and the clinical effectiveness of this and other
interventions remains unproven.” [7] “The reported effects of removal of pets from
homes are paradoxical, with either no benefit for asthma, or a potential for continued
high exposure to induce a degree of tolerance.” [5] [EPR-3 suggests that animal removal
could be considered but rates the evidence Grade D which reflects panel consensus only]
[6]
Secondary prevention-fungal allergen
avoidance and control measures
Uncertain “Air conditioners and dehumidifiers may be used to reduce humidity to levels less than
50% and to filter large fungal spore. However, air conditioning and sealing of windows
have also been associated with increases in fungal and house dust mite allergens.” [7]
“Although fungal exposure has been strongly associated with hospitalisation and increased
mortality in asthma, no controlled trials have addressed the efficacy of reduction of
fungal exposure in relation to control of asthma.” [5] “The Expert Panel recommends
consideration of measures to control indoor mold [...] but the relative contribution of
fungi, house-dust mites or irritants [to asthma symptoms] is not clear.” [6]
Secondary prevention-cockroach avoidance
and control measures
Uncertain “[Measures for cockroach control] are only partially effective in removing residual
allergens.” [7] “Cockroach allergy is not a common problem in the UK and studies of
attempts to avoid this allergen elsewhere have produced conflicting results.” [5] [EPR-3
recommends cockroach control if the patient is sensitive to cockroaches]. [6]
Secondary prevention-cessation of active
smoking
Beneficial “Secondhand smoke increases the frequency and severity of symptoms in children
with asthma.” [7] “Direct or passive exposure to cigarette smoke adversely affects quality
of life, lung function, need for rescue medications for acute episodes of asthma and long
term control with inhaled steroids.” [5] “[Smoke exposure] is associated with increased
symptoms, decreased lung function, and a greater use of health services among
those who have asthma.” [6]
Secondary prevention-avoidance of passive
smoking
Beneficial “Asthma patients who smoke and are not treated with inhaled glucocorticosteroids, have a
greater decline in lung function than asthmatic patients who do not smoke.” [7] “Direct or
passive exposure to cigarette smoke adversely affects quality of life, lung function, need
for rescue medications for acute episodes of asthma and long term control with inhaled
steroids.”[5] “[Smoke exposure] is associated with increased symptoms, decreased lung
function, and a greater use of health services among those who have asthma.” [6]
Secondary prevention-avoidance of
exposure to air pollution
Uncertain “Avoidance of unfavourable environmental conditions is usually unnecessary for patients
whose asthma is controlled.” [7] “While it might seem likely that moving from a highly
polluted environment might held, in the UK, asthma is more prevalent in 12-14 year
olds in non-metropolitan rather than metropolitan areas.” [5] “Clinicians [should] advise
patients to avoid, to the extent possible, exertion or exercise outside when levels of air
pollution are high.” [6]
Secondary prevention-immunotherapy for
a defined allergen
Beneficial “Appropriate immunotherapy requires the identification and use of a single well-
defined clinically relevant allergen.” [7] “Immunotherapy can be considered in patients
with asthma where a clinically significant allergen cannot be avoided.” [5]
“Immunotherapy [should] be considered for patients who have persistent asthma if
evidence is clear of a relationship between symptoms and exposure to an allergen.”
[6]
Secondary prevention-weight reduction in
obese patients
Beneficial “Weight reduction in obese patients with asthma has been demonstrated to improve lung
function, symptoms, morbidity and health status.” [7] “One randomised parallel group
study has shown improved asthma control following weight reduction in obese
patients with asthma.” [5] “Obesity has been associated with asthma persistence and
severity in both children and adults. [...W]eight loss in adults resulted in improvement in
pulmonary mechanics, improved FEV1, reductions in exacerbations and courses of oral
corticosteroids and improved quality of life.” [6]
Secondary prevention-seasonal influenza
vaccination
Uncertain “Patients with moderate to severe asthma should be advised to receive an influenza
vaccination every year [...] however routine influenza vaccination of children and
adults with asthma does not appear to protect them from asthma exacerbations or
improve asthma control.” [7] “Immunisations should be administered independent of
any considerations related to asthma.” [5] “[We recommend] that clinicians consider
inactivated influenza vaccination for patients who have asthma [...] however the vaccine
should not be given with the expectation that it will reduce either the frequency or
severity of asthma exacerbations during the influenza season.” [6]
Statements were extracted from the UK BTS/SIGN, US EPR-3 and international GINA guidelines.
’Uncertain’ was used when either all three guidelines agreed that the evidence base was uncertain or where the advice given by the guidelines differed. We
retained only topics discussed by all three sets of guidelines.
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emergency procedure prove ineffective, although two
contained details of conventional emergency manage-
ment in separate sections [35,36].
Compliance of information with evidence-based
recommendations
We identified 72 instances where apps addressed items
from our pre-defined set of evidence-based recommenda-
tions. Of these app-statements, 40 were asserted in line
with current guidance. In all other cases (n = 32), apps
appeared to unequivocally recommend a particular course
of action where there is current uncertainty. Statements
concerning active and passive smoke avoidance (exacer-
bates symptoms, n = 12 and 13), weight reduction in obe-
sity (beneficial for asthma symptoms, n = 7) and the
potential utility of immunotherapy (can be considered
where a specific allergen is identified, n = 2) were correctly
asserted by all apps that mentioned them. Recommenda-
tions about behavioural strategies for the avoidance of air
pollution (n = 9), fungal allergens (n = 9), removal (rather
than control of) pets (n = 5) and cockroach control (n = 7)
were all delivered more variably (breakdown in Additional
file 6). An unequivocal recommendation for flu vaccina-
tion was made by five of six apps.
A small number of apps actively cautioned against allo-
pathic medical management. Four apps [18,52,60,66]
recommended avoiding conventional medical manage-
ment because of the risks of side effects, addiction and
worsening of the condition.
Apps providing tools for the management of asthma
Diaries
Twenty-nine apps offered functions for patients to track
their asthma (Additional file 7[70-98]). Diaries differed in
Table 3 Health information best-practice principles adapted for smartphone apps
1 Information must be authoritative: all medical information presented by [and/or calculations performed by an app] must be attributed to an
author and his/her training in the field must be mentioned.
2 Purpose [of the app]: A statement clearly declaring that the [app] is not meant to replace the advice of a health professional has to be provided.
A brief description of the [app]’s mission, purpose and intended audience is necessary. Another brief description of the organisation behind the
[app], its mission and its purpose is also necessary.
3 Confidentiality: The [app publisher] must describe its privacy policy regarding how you treat confidential, private or semi-private information such
as email addresses and the content of emails received from or sent to [its users]
4 Information must be documented, referenced and dated: All medical content [including calculations and formulae] has to have a specific date of
creation and a last modification date.
5 Justification of claims: All information about the benefits or performance of any treatment (medical and/or surgical), commercial product or
service are considered as claims. All claims have to be backed up with scientific evidence (medical journals, reports or others).
6 [App] contact details: The [app] must be operational and the information must be accessible and clearly presented. There must be a way to
contact the [app publisher], such as a working email address or contact form, for visitors who would like to have more details or support.
7 Funding: [The app publisher] must include a statement declaring its sources of funding.
8 Editorial and advertising policy: Conflicts of interest and external influences which could affect the objectivity of the editorial content must be
clearly stated in the disclaimer. All [apps] displaying paying banners have to have an advertising policy. This policy must explain how the
[publisher] distinguishes between editorial and advertising content and which advertisements are accepted. Any conflict of interest has to be
explained.
Adapted from the Health on The Net Foundation principles for health information on the internet.
Table 4 Classes of software issue considered during assessment
Issue type Description Example(s)
Data entry
validation
Data can be entered that are out-of-range or inappropriate. New
data can overwrite existing data without warning.
Negative values of peak flow can be entered and are stored.
New entries can overwrite existing data without warning.
Functionality A function of the app (for example, saving data, performing a
calculation) does not operate as expected.
App miscalculates the score of Asthma Control Test for
adults; app displays an ‘unfortunately you did not beat your
highest score’ message even if score is 100%.
Presentation
and user
interface (UI)
Content having spelling and layout mistakes. User interface controls
(for example, textboxes, labels, buttons) are mislabelled, inoperative
or inaccessible. Navigation between different parts of the app does
not occur as expected or can lead to the user getting stuck on a
particular screen.
Some controls hidden when opened on a lower resolution
screen; text box for recording peak flow labelled as ‘Peek
Flow’; some user controls not labelled in English.
Crash The app stopped responding in a timely way to user input or was
closed unexpectedly by the smartphone or tablet operating system.
App crashed when a backup of data entered by the user
was attempted.
Other Any other software issue, for example an online or other data
service (for example, a website that the app uses for data) is
unavailable or does not work as expected.
Some linked content that is displayed within the app on
allergens is broken; GPS function does not work.
The table summarizes the classes of error used for assessment and provides illustrative examples based on those observed during the appraisal process.
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options given to patients for manipulating the recorded
data. While a small number of diaries captured either
asthma symptoms (n = 2 [87,88]) or peak flow (n = 2
[93,94]) alone, the majority (n = 23) allowed both symp-
toms and peak flow values to be recorded as well as
recent medication use (n = 24). Most apps relied on man-
u a le n t r yo fd a t a ;h o w e v e r ,o n e[ 9 2 ]w a sa b l et os o u r c e
values from a Bluetooth-enabled peak flow meter and
another (available on both iPhone and Windows Phone)
from a wireless inhaler [96,97] (untested in this review).
Fifty-nine percent of (n = 17 of 29) diary apps lacked data
validation to prevent out-of-range values to be entered
[71,73-77,79-82,86,90,93-96,98]. Five diaries allowed custo-
mized self-management plans [76,77,84,89,92] that
included emergency care instructions and prescribing
details for different classes of medication. Four
[76,77,84,92] used a three-step action plan with traffic
light colouring consistent with guideline recommendations
[11]. However, none were able to vary the number of steps
in the action plan, nor the thresholds at which the action
plan steps were triggered (50 and 80%). All four used peak
flow values entered in the diary to trigger a display of
steps to be taken by the patient based on their action plan.
Although recommended by guidelines, none included an
equivalent function based on recorded symptoms.
Five apps [82,90,95-97] provided a function to track
the doses remaining in their pressured Metered-Dose
Inhaler (pMDI). Each app used a similar approach,
providing a visual warning when the device was running
low.
Assessment instruments
The sources and scoring mechanisms of asthma status
questionnaires embedded in seven [82,89,99,100,106-108]
were reviewed (Additional file 8). Only one app cited the
source [82], assigning a numeric score based on Global
Initiative for Asthma criteria for asthma control [7]. How-
ever, while these criteria exist [7], we could find no vali-
dated approach that recommends assigning a numeric
score to each criterion and presenting the result as an
aggregate sum. One [99] used, without attribution, the
adult and paediatric versions of a standard instrument, the
Asthma Control Test [116,117]. Scoring errors were found
in the adult version, which meant that no matter how
minimal an individual’s current symptoms, the app would
always recommend seeking medical help. We could not
find validation information for any of the other tools.
Three iPhone apps [101-103] used the device micro-
phone to analyse breath sounds and provided diagnostic
commentary, for example, the identification of wheeze.
We were unable to locate validation information for these
diagnostic tools.
Seven apps incorporated predicted peak flow calculators
as either a dedicated calculator (n = 3 [104,105,118]) or
within a diary to generate reference values for charting
(n = 4 [80,81,83,94]). Only one of the calculators [118]
provided attribution. We were able to identify the calcula-
tion algorithm for one other [105]. Both had bugs which
1 
 
 
 
 
Figure 2 Flowchart of app selection process.
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circumstances. One [105] would silently forget the gender
of the patient and subsequently provide male predicted
values if the device was physically rotated to change from
a portrait to landscape screen display. The other had a sys-
tematic error where female predicted values were returned
for individuals five inches shorter in height than those
entered [118]. Despite writing to the publishers, we could
not identify the underlying algorithm for the third calcula-
tor or any but one of the diary apps [83], the performance
of which could not be verified because of problems enter-
ing data. Only one acknowledged the use of different peak
flow measurement scales by allowing the user to pick
which type of meter they used [94].
Other tools
Six apps provided location-based pollen or pollution alerts
for users in the United States and Ireland [70,109-113]
(Additional file 9). One product - available as apps on
both Blackberry [115] and Apple [114] devices - did not fit
into the categories of tools described above, offering paid-
for audio recordings of Indian chants intended for use by
those with a range of conditions including asthma.
Compliance with health information best-practice
principles
The purpose of the app was clearly stated or interpretable
in 86% of health information apps (n = 48) and 96% of
management tools (n = 45). Content authorship was stated
in 18 of 56 (32%) health information apps. Six apps
[19,29,35,36,48,66] were eBook versions of texts originally
available in hard copy. Where information was not attribu-
ted, we searched online in an attempt to locate any origi-
nal source. A quarter of information apps (n = 14, of
w h i c h1 0w e r ep a i df o r )u s e dc o n t e n ta v a i l a b l ef r e e l y
online without attribution, for example, from Wikipedia
[20,25]. In a further five cases [18,31,33,34,57], we found
matched content online but it was unclear whether repro-
duction was authorized. The date of content creation was
identified for only one app [27] and none provided a con-
tent expiry date. Only one provided details of its editorial
policy through a linked website [27].
An explicit confidentiality policy - found either in the
app or on an associated website - was identified for only
5 of 29 apps (17%) in which personal data could be
recorded [70,72,82-84]. Four apps offered a password pro-
tection mechanism to assist in securing data [78,83,84,96].
We were able to identify the funding source for the app in
23 cases: 2 were sponsored by local US government
[109,110]; one medication tracker [95] (and 2 German-lan-
guage apps excluded from the analysis [119,120]) were
sponsored by pharmaceutical companies; 2 by a company
developing an electronic inhaler [96,97] and the rest by
commercial companies Twenty-two apps incorporated
advertisements but none detailed an advertising policy.
Most (n = 17) were for products unrelated to health and
the remainder promoted content offered by the same pub-
lisher. Third party endorsements were present for two
apps; from the US National Institutes of Health [59] and
the UK Department of Health [27], under the Information
Quality Mark scheme. Fifty-five percent of all apps offered
a means to contact the authors using either email (n = 41),
an online form (n = 14) or an in-app form (n = 2).
Discussion
We systematically assessed all available asthma apps to
ascertain whether they would be appropriate for prescrip-
tion by health professionals by meeting existing quality
standards for asthma self-management information and
tools. Although our search identified 103 English language
asthma apps, none combined comprehensive, evidence-
based information with reliable supportive tools.
While the majority of information apps presented
incomplete content that does not address the breadth of
topics recommended for people living with asthma, a few
did. Asthma Consultant for Blackberry [59], Truth About
Asthma for Android [63] and Asthma for iPhone [19]
addressed the widest range of topics and provide guidance
consistent with US guidelines. Focussing on childhood
asthma, Child Health for iPhone [27] is noteworthy
because it most completely complied with standards for
the presentation of health information. No apps provided
comprehensive advice about lay management of acute
asthma and a small number of CAM apps made recom-
mendations that are likely to be ineffectual or may be
harmful.
Inconsistencies were also seen in apps that offered tools.
Peak flow and symptom diaries, although generally reli-
able, often lack basic features, such as data entry valida-
tion, and, consequently, no particular app stood out in this
group. Peak flow calculators and questionnaire-based apps
designed for use by people with asthma (as distinct from
those targeting clinicians which were not assessed in this
review) appear to be unreliable and should not be used:
we were unable to identify the underlying calculation for
most; numeric errors were present in those that we could
verify and only one attempted to compensate for differ-
ences in readings from different peak flow meter types.
These findings have a number of consequences for clini-
cians, who may be considering using apps as part of rou-
tine asthma care. First, no current app can meet the needs
of every patient. Instead, clinicians will need to draw from
the diverse range of options. This requires that they them-
selves become familiar with a large number of apps, or
that appropriate guidance is available to them. Second,
because information apps have different levels of informa-
tion coverage, they must identify, or have identified for
them, the gaps in those apps that are in use and tailor
their education to address these. Third, clinicians must
Huckvale et al. BMC Medicine 2012, 10:144
http://www.biomedcentral.com/1741-7015/10/144
Page 8 of 11consider how best to support people who choose their
own app, particularly where the advice it contains differs
from current practice. The potential complexity of these
tasks suggests that there may be something of a missed
opportunity to combine comprehensive information and
tools in a single app.
Health professionals, particularly GPs with very limited
consultation time, face broader issues in prescribing apps
that function as self-management tools. Patients may need
help addressing technical issues, such as installing an app
or fixing it if it crashes. Apps that enable the creation of
action plans or data collected into diaries require new
ways of working to populate those records, review data
and respond in a timely fashion. If data are being trans-
ferred from patient devices, clinicians must think about
how those data will be integrated into patient records and
their responsibilities for data security.
The quality gaps we identified in asthma apps, and simi-
lar findings for iPhone apps for smoking cessation [121]
and weight loss [122] available in 2009, should prompt
caution in health professionals and policy makers thinking
about the imminent introduction of apps into long-term
condition care. While we recognize that apps are, and will
remain, a rapidly developing field, and that higher quality
apps may (always) be available in the near future, the
classes of issues we have identified will persist. They serve
to highlight some of the actions necessary to translate
apps from opportunity to implementation. Specifically,
mechanisms of quality control and greater conceptualiza-
tion and validation of the role of apps in clinical care need
to be addressed.
There are many existing mechanisms for quality assur-
ance in medicine that could be applied to apps. As we
have shown, guidelines and standards for condition-speci-
fic information and information-use more generally exist
and can provide criteria against which to assess app con-
tent. Similarly, for each condition, validated tools exist
that can be appropriated (with appropriate attribution),
allowing assurance to focus on correct implementation
rather than the content of the tool. Processes from medi-
cal device regulation could provide guidance on ways to
tackle quality assurance of technological aspects, such as
the reliability and data validation problems highlighted in
this review.
Guideline-derived quality criteria, such as ours, have a
rational basis from a clinical point of view but have lim-
itations. First, the modes of delivery envisaged when
guidelines were written may be a poor match with apps.
For example, paper-based asthma action plans lack the
interactive treatment recommendations offered by most
of the app-based plans in our review. Second, some qual-
ity issues may not result in actual harm, either because
they are readily detected or because their effects are
minimal in practice. Quality may also be judged differ-
ently by patient users of the app, who must find that a
specific app meets their own goals and stimulates sus-
tained use. Early evidence is equivocal about whether
mobile apps for asthma self-management are better than
existing paper-based methods: of the two medium-sized
randomized trials identified as part of an on-going sys-
tematic review [123], one, a Taiwanese trial of an asthma
diary app demonstrated reductions in exacerbations and
unscheduled care use [124] while the second, a UK-based
trial of a similar app, did not [125]. Future work should
seek to understand the range of dimensions that play a
part in making apps effective. Promoting reliable, evi-
dence-based apps is only the starting point to exploring
the role of apps as part of long-term condition care.
Policy makers will need to consider the best ways to
combine existing appraisal processes or build new ones to
promote app quality assurance in all of its angles. Possibili-
ties include making app assessment part of the remit of
guideline groups, requesting systematic reviews of content
similar to this paper, self- or third-party accreditation, full
regulation, usage studies and recommender systems. Any
of these solutions will need to account for the dual issues
of content assessment and technology reliability and safety
which have traditionally been done by different groups.
They will also need to attend to the tension between the
desire to limit risk to patients and the barrier that assur-
ance creates in terms of cost and effort in what is, and will
remain, a rapidly evolving field. This tension is not new.
Commentary on previous technology innovations, for
example, the emergence of the internet as a source of
health information, has highlighted the risk of mismatch
between standards proposed for new media and those
seen in existing media [126,127]. Any assurance strategy
should be demonstrably effective in helping clinicians -
and people with asthma - identify high quality apps appro-
priate to their needs.
Conclusions
Little evidence exists around the content quality of apps
for long-term conditions, although limited adherence to
evidence-based guidelines has been found in apps for
behavioural interventions, like smoking and weight loss.
This systematic assessment of apps for asthma provides
insight into the types of quality issues that can affect
apps for long-term conditions as well as a replicable and
updatable method for assessment. Issues include limited
and inaccurate information, faulty tools and content-
independent problems of information presentation and
attribution. The findings highlight a need for caution
among clinicians thinking about using apps as part of
clinical care and for policy-makers and developers to
consider appropriate ways of assuring content quality in
Huckvale et al. BMC Medicine 2012, 10:144
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Page 9 of 11health apps. There is much to be done: clinicians cannot
recommend tools that are inaccurate, unsafe or lack an
evidence base.
Additional material
Additional file 1: Data extraction template. The template was used
during data extraction to standardize the process. Descriptions are
provided for items that may be unclear. Section 8 contains a
comprehensive list of evidence-based statements derived from UK BTS/
SIGN guidelines which is a superset of those reported in the study and is
intended for a separate analysis of the suitability of apps for use in a UK-
specific context.
Additional file 2: Characteristics of excluded apps. The table
summarizes the apps excluded during screening and the reasons for
exclusion.
Additional file 3: App types identified by the systematic
assessment. The table shows a numeric breakdown of the types of
content and features exposed by apps included in the assessment.
Additional file 4: Characteristics and quality appraisal of apps
presenting information about asthma. Methods used for quality
appraisal are described in the text.
Additional file 5: Comprehensiveness of educational topic coverage
by health information apps. The table summarizes the number of apps
addressing each of eight topics defined for asthma self-management
education. Each app was assessed as either addressing the domain
wholly, partially or not at all, using defined sub-criteria, which are
described separately.
Additional file 6: Consistency of recommendations made by asthma
apps with evidence-base. The table shows the number of references to
each statement made by apps included in the assessment and the
direction of any recommendation associated with that statement. For
example, an app claiming that removing pets from the home is
beneficial for asthma symptom control would count under the
‘Beneficial’ column. The expected advice (in the example given: that
there is no clear evidence that removal of pets from the home improves
asthma symptoms) is shown for each statement in the shaded box.
Additional file 7: Characteristics and quality appraisal of diary apps.
Methods used for quality appraisal are described in the text.
Additional file 8: Characteristics and quality appraisal of apps
providing assessment tools. Methods used for quality appraisal are
described in the text.
Additional file 9: Characteristics of other apps. The table summarizes
apps not fitting into other categories.
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